Fig. 4From: Longitudinal tumor hypoxia imaging with [18F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activityRepresentative H&E stained tumor sections (20× magnification, day 16) showing a decrease in cellular density following treatment with nal-IRI at a dose of 10 mg/kg compared to treatment with nal-IRI at 5 mg/kg and treatment with irinotecan at 50 mg/kgBack to article page